Capponi Vincent — SEC insider filings
SEC reporting owner CIK 1368151. 15 insider filings on record with FilingPulse; latest filed 2026-09-16.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2021-04-14 to 2026-09-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 8 legs across 5 filings — 30,870 shares, $57,301 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: purchase of 18,797 shares @ $1.33 ($25,000) in Cytosorbents Corp, filed 2023-12-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cytosorbents Corp (CTSO) | President and COO | 15 | 8 legs · 30,870 sh · $57,301 | — | 24 |
Insider filings — Capponi Vincent
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-16 | 4 | Cytosorbents Corp (CTSO) | Purchase (P): 1,800 @ $6.07 · Purchase (P): 273 @ $5.90 | EDGAR |
| 2025-08-08 | 4 | Cytosorbents Corp (CTSO) | Grant/award (A): 89,100 @ $0 · Grant/award (A): 111,100 (derivative) @ $0 | EDGAR |
| 2025-02-26 | 4 | Cytosorbents Corp (CTSO) | Code (O): 12,000 @ $1.13 · Code (O): 12,000 (derivative) @ $1.13 | EDGAR |
| 2025-01-22 | 4 | Cytosorbents Corp (CTSO) | Option exercise/expiry (X): 31,760 @ $1 · Option exercise/expiry (X): 31,760 (derivative) @ $0 · Other (J): 31,760 (derivative) · Other (J): 31,760 (derivative) | EDGAR |
| 2024-10-08 | 4 | Cytosorbents Corp (CTSO) | Grant/award (A): 100,000 (derivative) · Grant/award (A): 50,000 (derivative) | EDGAR |
| 2024-04-04 | 4 | Cytosorbents Corp (CTSO) | Grant/award (A): 81,000 @ $0 · Grant/award (A): 101,000 (derivative) | EDGAR |
| 2024-04-02 | 4 | Cytosorbents Corp (CTSO) | Grant/award (A): 48,923 (derivative) | EDGAR |
| 2023-12-15 | 4 | Cytosorbents Corp (CTSO) | Purchase (P): 18,797 @ $1.33 · Purchase (P): 6,578 (derivative) | EDGAR |
| 2023-07-11 | 4 | Cytosorbents Corp (CTSO) | Grant/award (A): 73,000 @ $0 · Grant/award (A): 91,000 (derivative) @ $0 · Grant/award (A): 42,000 (derivative) @ $0 | EDGAR |
| 2023-04-05 | 4 | Cytosorbents Corp (CTSO) | Option exercise (M): 10,000 @ $2.88 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2022-08-12 | 4 | Cytosorbents Corp (CTSO) | Grant/award (A): 69,000 @ $0 · Grant/award (A): 86,000 (derivative) @ $0 · Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2022-06-22 | 4 | Cytosorbents Corp (CTSO) | Purchase (P): 2,000 @ $1.80 | EDGAR |
| 2022-06-21 | 4 | Cytosorbents Corp (CTSO) | Purchase (P): 3,000 @ $2 | EDGAR |
| 2022-05-25 | 4 | Cytosorbents Corp (CTSO) | Purchase (P): 1,574 @ $2.04 · Purchase (P): 299 @ $2.02 · Purchase (P): 3,127 @ $2.03 | EDGAR |
| 2021-04-14 | 4 | Cytosorbents Corp (CTSO) | Grant/award (A): 62,215 @ $8.99 · Grant/award (A): 78,200 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-04-07 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1368151 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs